http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102675228-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6dca1f52ec4409108717543c8c6f0c65 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4965 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-12 |
| filingDate | 2011-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bed3ca20fd0629d8eafdd7583eba202a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59c850f70db8380210a62080fbeae634 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48cfabef5f6ffdf358c86182411ff2fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_208e147472b2f14765df28c9e187c3b2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27dcbe07f1c780a83a05570c52e719e7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40bd55a98e66ec36f57f429018e94334 |
| publicationDate | 2014-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102675228-B |
| titleOfInvention | Medicine for treating ischemic brain injury stroke and sequela of ischemic brain injury stroke and preparation method for medicine |
| abstract | The invention discloses a structural general formula of a compound LQC-T and the synthesis and the application of the compound LQC-T. Pharmacological experiments prove that the compound has an obvious effect of promoting new vessels of chick chorioallantoic membranes to grow; a compound LQC-T4 has an obvious medicinal effect of treating ischemic brain injury stroke and the sequela of the ischemic brain injury stroke; the maximal LQC-T4 single-day dose of mice is 5400mg/kg; and the compound is extremely high in safety and can be used for preparing a medicine for treating the ischemic brain injury stroke and the sequela of the ischemic brain injury stroke after toxic responses do not occur after continuous observation within 1 to 4 days. According to the structural formula of the compound LQC-T, R is protocatechuic acid, protocatechuic aldehyde, vanillic acid, gallic acid, caffeic acid, ferulic acid and other aromatic organic acids or phenols or structural analogues of the organic acids or phenols. |
| priorityDate | 2011-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 89.